Evidence map›Paper›PMID 34837114›Full record

ArticleMikrochimica acta2021

Voltammetric sensor based on bimetallic nanocomposite for determination of favipiravir as an antiviral drug.

Mohammad Mehmandoust, Yasamin Khoshnavaz, Mustafa Tuzen, Nevin Erk

Open access · bronzeAbstract read
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Mohammad MehmandoustDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey. mehmandoust@ankara.edu.tr.
Yasamin KhoshnavazDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey.
Mustafa TuzenDepartment of Chemistry, Faculty of Science & Arts, Tokat Gaziosmanpaşa University, Tr-60250, Tokat, Turkey.
Nevin ErkDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey. erk@pharmacy.ankara.edu.tr.
Ankara University · TRSakarya University · TRTokat Gaziosmanpaşa Üniversitesi · TR

Funding

ankara universitesi 21B0237005
6 · The paper itself

Abstract

A novel and sensitive voltammetric nanosensor was developed for the first time for trace level monitoring of favipiravir based on gold/silver core-shell nanoparticles (Au@Ag CSNPs) with conductive polymer poly (3,4-ethylene dioxythiophene) polystyrene sulfonate (PEDOT:PSS) and functionalized multi carbon nanotubes (F-MWCNTs) on a glassy carbon electrode (GCE). The formation of Au@Ag CSNPs/PEDOT:PSS/F-MWCNT composite was confirmed by various analytical techniques, including X-ray diffraction (XRD), ultraviolet-visible spectroscopy (UV-Vis), transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDX), and field-emission scanning electron microscopy (SEM). Under the optimized conditions and at a typical working potential of + 1.23 V (vs. Ag/AgCl), the Au@Ag CSNPs/PEDOT:PSS/F-MWCNT/GCE revealed linear quantitative ranges from 0.005 to 0.009 and 0.009 to 1.95 µM with a limit of detection 0.46 nM (S/N = 3) with acceptable relative standard deviations (1.1-4.9 %) for pharmaceutical formulations, urine, and human plasma samples without applying any sample pretreatment (1.12-4.93%). The interference effect of antiviral drugs, biological compounds, and amino acids was negligible, and the sensing system demonstrated outstanding reproducibility, repeatability, stability, and reusability. The findings revealed that this assay strategy has promising applications in diagnosing FAV in clinical samples, which could be attributed to the large surface area on active sites and high conductivity of bimetallic nanocomposite.

Indexed as

COVID-19 Drug TreatmentAmidesAntiviral AgentsColloidsElectrochemistryElectrodesGoldHumansLimit of DetectionLinear ModelsMetal NanoparticlesNanocompositesNanomedicineNanotechnologyNanotubesPolymersAmidesAntiviral AgentsColloidsfavipiravirGoldPolymersPyrazinesBiological sample analysisCarbon nanotubeConductive polymerCOVID-19FavipiravirVoltammetry

Identifiers

PMID34837114
PMCPMC8626286
OpenAlexW3214785184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.